feed,title,long_url,short_url
Yahoo,Gilead Analyst: FDA's Remdesivir Label A Best Case Scenario For Biopharma,https://finance.yahoo.com/news/gilead-analyst-fdas-remdesivir-label-163104783.html,https://yhoo.it/3jqDHjQ
